Healthcare Realty Trust Incorporated (HR)
(Delayed Data from NYSE)
$17.46 USD
-0.06 (-0.34%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $17.46 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth B Momentum C VGM
Healthcare Realty Trust (HR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$17.67 | $20.00 | $16.00 | 1.20% |
Price Target
Based on short-term price targets offered by nine analysts, the average price target for Healthcare Realty Trust comes to $17.67. The forecasts range from a low of $16.00 to a high of $20.00. The average price target represents an increase of 1.2% from the last closing price of $17.46.
Analyst Price Targets (9 )
Broker Rating
Healthcare Realty Trust currently has an average brokerage recommendation (ABR) of 2.45 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 2.45 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, three are Strong Buy, representing 27.27% of all recommendations. A month ago, Strong Buy represented 27.27%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/HR.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 8 | 8 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.45 | 2.45 | 2.45 | 2.45 | 2.45 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/8/2024 | Not Identified | Not Identified | Hold | Hold |
6/20/2024 | Not Identified | Not Identified | Hold | Hold |
5/13/2024 | Wells Fargo Securities | James Feldman | Not Available | Hold |
5/8/2024 | Scotiabank | Nicholas Yulico | Hold | Hold |
5/8/2024 | Wedbush Securities | Richard Anderson | Hold | Hold |
1/2/2024 | BTIG | Michael Gorman | Strong Buy | Strong Buy |
10/7/2023 | KeyBanc Capital Markets | Austin Wurschmidt | Hold | Hold |
10/6/2023 | BMO Capital Markets | Juan Sanabria | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.45 |
ABR (Last week) | 2.45 |
# of Recs in ABR | 11 |
Average Target Price | $17.67 |
LT Growth Rate | NA |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 93 of 252 |
Current Quarter EPS Est: | 0.38 |